trending Market Intelligence /marketintelligence/en/news-insights/trending/7lPzDxPtB2mgKYAO0r60zQ2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Vericel plans common stock offering

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Vericel plans common stock offering

Vericel Corp. plans to offer and sell common shares in an underwritten public offering.

The company also intends to grant the underwriters an option to buy up to an additional 15% of shares sold in the offering on the same terms and conditions.

Vericel will primarily use the net proceeds to support the commercialization of MACI, expand promotional efforts for Epicel, expand and optimize manufacturing and for other general corporate purposes.

Piper Jaffray & Co. is acting as the sole book runner for the offering.